Biomarkers in the eyes could play a part in helping manage diabetic retinopathy and potentially diabetes, says new research from the Indiana University School of
The FDA has approved an extended-release version of the GLP-1 drug exenatide for older children and teenagers with Type 2 diabetes, Andrew Briskin report for
JDRF’s 100 challenge is a fundraiser for World Diabetes Day to mark the discovery of insulin 100 years ago – a breakthrough that has saved
Results of an AI technology trial at Barts Health NHS Trust show potential to prevent thousands of people with diabetes from limb amputation. The study
By Ricky Zipp writing for MedTechDive July 2021, “Dexcom wins FDA nod for real-time artificial pancreas systems (APIs), allowing third-party developers access to CGM data
Walmart has launched the first-ever private brand analogue insulin in the United States, offering customers significant price savings without compromising quality. Manufactured by Novo Nordisk,
A charity is calling for more accessible technology to help blind and partially sighted people better manage their diabetes. The RNIB shared Joanna Penn’s story
On 14 July Eli Lilly and Company announced the acquisition of Protomer Technologies (“Protomer”), a private biotech company. Protomer’s proprietary peptide- and protein-engineering platform is
ViaCyte has closed a $45m Series D financing tranche in the United States, bringing the total round to more than $115m, reports DrugDeliveryBusiness.com. The funding will
Diabetes UK Cymru has awarded the John Macleod medal to a man living with Type 1 diabetes for 70 years. Reverend Dr John Dann, 88,
